SEC reqs about the 15-12g filing that have protected the shell for 11 years while it was quiet, require Hovis and any other officers and directors to stay silent until the company is fully reporting again, either by re-registering the shares with the SEC and going back to fully reporting, or by using the Alt-filing method with the OTC.
But no new shares, like the shares the CCA, LLC folks will soon swap for CCA, LLC shares/Biotech assets, can only be registered and sold no sooner than a year later after and until they go back to fully reporting with the SEC S-1/1-A filing first, and then its a year before they could sell any of their shares to retail, meaning the 290,000 share float is all there is for this beast for a year starting the day they go back to fully reporting.
Until then they in a gagged, quiet, unable to talk legally, quite period. To talk to us and tell us "when the lights go on and how" before they are SEC current would risk the SEC suspending trading and sending us to grey sheets.
It is the price we pay for getting in early.
Only reason we have any clue what is coming, is because the Court-Judge appointed Custodian had to notify shareholders of the shareholder meeting and checklist of items to be approved at that meeting, in which the CCA, LLC R/M was the only item on a list of almost 10 things they were going to approve at that shareholder meeting.
My DD and digging is how we found out what was inbound, because CCA, LLC, a private Biotech, had filed an SEC filing in 2016 that disclosed what they have and who they are.
That shareholder letter in October last year, also confirmed they still had the UPennMed Research Joint Venture, joint ownership deal between the firm (CCA, LLC) R/M with Milv to form NDTP.
So no, in fact if they were telling us anything, I would be freaking out selling fast during this dark period.
The fact they are and have been, have stayed gagged all this time tells me this is not a scam, and tells me it is real.
What news we have seen/found the hard way was public filings with OTCmarkets and the Nevada SOS (Listing the CEO, James Hovis, and the company attorney that a search tells us is a specialist in SEC S-1/1-A filings (BINGO Baby), FINRA-ticker and Name change, and stuff we mined the hard way like finding the web site registered to one of the CCA, LLC major shareholders.
This is as good as it gets at this stage.
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
